Company intelligence / Profile preview

Kasiak Research

Mumbai, India

Ownership: Private
Development stage: Other

Overview

Kasiak Research, a subsidiary of Bharat Serums and Vaccines (BSV), is a pre-clinical biotech company specializing in injectable cell therapy using mesenchymal stem cells from donor bone marrow. Its pipeline includes one program for Critical Limb Ischemia. The company's information dates primarily to 2016 articles, with no recent updates or detailed clinical data publicly available.

Therapeutic areas: Cardiovascular
Modalities: Cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Kasiak Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kasiak Research.

Explore the full profile